- VASCEPA Approved by the National Medical Products Administration (NMPA) as an Adjunct to Diet to Reduce Triglyceride Levels in Adult Patients with Severe Hypertriglyceridemia (≥ 500 mg/dL) --
-- EddingPharm Now Working Towards Preparing for Commercial Launch of VASCEPA Across Mainland China Expected by Year-End --
https://finance.yahoo.com/news/amarin-partner-eddingpharm-receives-regulatory-100000116.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.